• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

来自四氯化碳诱导的急性大鼠损伤模型的血清可诱导脂肪干细胞向肝细胞分化,并减轻肝纤维化。

Serum from CCl-induced acute rat injury model induces differentiation of ADSCs towards hepatic cells and reduces liver fibrosis.

作者信息

Baig Maria Tayyab, Ali Gibran, Awan Sana Javaid, Shehzad Umara, Mehmood Azra, Mohsin Sadia, Khan Shaheen N, Riazuddin Sheikh

机构信息

a Centre of Excellence in Molecular Biology , University of Punjab , Lahore , Pakistan.

b Cardiovascular Research Centre, Lewis Katz School of Medicine at Temple University , Philadelphia , PA , USA.

出版信息

Growth Factors. 2017 Oct;35(4-5):144-160. doi: 10.1080/08977194.2017.1392945. Epub 2017 Nov 7.

DOI:10.1080/08977194.2017.1392945
PMID:29110545
Abstract

Cellular therapies hold promise to alleviate liver diseases. This study explored the potential of allogenic serum isolated from rat with acute CCl injury to differentiate adipose derived stem cells (ADSCs) towards hepatic lineage. Acute liver injury was induced by CCl which caused significant increase in serum levels of VEGF, SDF1α and EGF. ADSCs were preconditioned with 3% serum isolated from normal and acute liver injury models. ADSCs showed enhanced expression of hepatic markers (AFP, albumin, CK8 and CK19). These differentiated ADSCs were transplanted intra-hepatically in CCl-induced liver fibrosis model. After one month of transplantation, fibrosis and liver functions (alkaline phosphatase, ALAT and bilirubin) showed marked improvement in acute injury group. Elevated expression of hepatic (AFP, albumin, CK 18 and HNF4a) and pro survival markers (PCNA and VEGF) and improvement in liver architecture as deduced from results of alpha smooth muscle actin, Sirius red and Masson's trichome staining was observed.

摘要

细胞疗法有望缓解肝脏疾病。本研究探索了从急性四氯化碳(CCl)损伤大鼠中分离出的异体血清将脂肪来源干细胞(ADSCs)诱导分化为肝系细胞的潜力。CCl诱导急性肝损伤,导致血清中血管内皮生长因子(VEGF)、基质细胞衍生因子1α(SDF1α)和表皮生长因子(EGF)水平显著升高。将ADSCs分别用从正常和急性肝损伤模型中分离出的3%血清进行预处理。ADSCs表现出肝脏标志物(甲胎蛋白、白蛋白、细胞角蛋白8和细胞角蛋白19)表达增强。将这些分化后的ADSCs肝内移植到CCl诱导的肝纤维化模型中。移植一个月后,急性损伤组的纤维化程度和肝功能(碱性磷酸酶、谷丙转氨酶和胆红素)均有显著改善。观察到肝脏标志物(甲胎蛋白、白蛋白、细胞角蛋白18和肝细胞核因子4α)和促生存标志物(增殖细胞核抗原和VEGF)表达升高,并且根据α平滑肌肌动蛋白、天狼星红和Masson三色染色结果推断肝脏结构有所改善。

相似文献

1
Serum from CCl-induced acute rat injury model induces differentiation of ADSCs towards hepatic cells and reduces liver fibrosis.来自四氯化碳诱导的急性大鼠损伤模型的血清可诱导脂肪干细胞向肝细胞分化,并减轻肝纤维化。
Growth Factors. 2017 Oct;35(4-5):144-160. doi: 10.1080/08977194.2017.1392945. Epub 2017 Nov 7.
2
In vitro differentiated hepatic oval-like cells enhance hepatic regeneration in CCl -induced hepatic injury.体外分化的肝卵圆样细胞增强了四氯化碳诱导的肝损伤中的肝再生。
Cell Biol Int. 2017 Jan;41(1):51-61. doi: 10.1002/cbin.10699. Epub 2016 Nov 13.
3
Adipose-derived mesenchymal stem cells inhibit activation of hepatic stellate cells in vitro and ameliorate rat liver fibrosis in vivo.脂肪来源的间充质干细胞在体外抑制肝星状细胞的活化,并在体内改善大鼠肝纤维化。
J Formos Med Assoc. 2015 Feb;114(2):130-8. doi: 10.1016/j.jfma.2012.12.002. Epub 2013 Feb 8.
4
Alpha lipoic acid priming enhances the hepatoprotective effect of adipose derived stem cells in CCl4 induced hepatic injury in-vitro.α-硫辛酸预孵育增强脂肪来源干细胞在 CCl4 诱导的体外肝损伤中的肝保护作用。
Eur J Pharmacol. 2021 Sep 5;906:174201. doi: 10.1016/j.ejphar.2021.174201. Epub 2021 Jun 9.
5
[Effect of adipose tissue-derived mesenchymal stem cell transplantation in treatment of liver fibrosis and possible mechanism].脂肪组织来源的间充质干细胞移植治疗肝纤维化的效果及可能机制
Zhonghua Gan Zang Bing Za Zhi. 2018 Jan 20;26(1):28-33. doi: 10.3760/cma.j.issn.1007-3418.2018.01.008.
6
Preconditioning of Adipose-Derived Mesenchymal Stem-Like Cells with Eugenol Potentiates Their Migration and Proliferation In Vitro and Therapeutic Abilities in Rat Hepatic Fibrosis.丁香酚预处理脂肪间充质干细胞样细胞增强其体外迁移和增殖能力,并在大鼠肝纤维化中增强其治疗能力。
Molecules. 2020 Apr 26;25(9):2020. doi: 10.3390/molecules25092020.
7
Basic fibroblast growth factor-treated adipose tissue-derived mesenchymal stem cell infusion to ameliorate liver cirrhosis via paracrine hepatocyte growth factor.碱性成纤维细胞生长因子处理的脂肪组织来源间充质干细胞输注通过旁分泌肝细胞生长因子改善肝硬化
J Gastroenterol Hepatol. 2015 Jun;30(6):1065-74. doi: 10.1111/jgh.12893.
8
The therapeutic potential of human umbilical mesenchymal stem cells from Wharton's jelly in the treatment of rat liver fibrosis.来自华通氏胶的人脐带间充质干细胞在大鼠肝纤维化治疗中的治疗潜力。
Liver Transpl. 2009 May;15(5):484-95. doi: 10.1002/lt.21715.
9
Adipose-derived stromal cells resemble bone marrow stromal cells in hepatocyte differentiation potential and .脂肪来源的基质细胞在肝细胞分化潜能上类似于骨髓基质细胞。
World J Gastroenterol. 2017 Oct 14;23(38):6973-6982. doi: 10.3748/wjg.v23.i38.6973.
10
Enhanced hepatic differentiation of mesenchymal stem cells after pretreatment with injured liver tissue.预处理受损肝组织后增强间充质干细胞的肝向分化。
Differentiation. 2011 Jan;81(1):42-8. doi: 10.1016/j.diff.2010.08.005. Epub 2010 Oct 12.

引用本文的文献

1
Curcumin preconditioning enhances the efficacy of adipose-derived mesenchymal stem cells to accelerate healing of burn wounds.姜黄素预处理可提高脂肪间充质干细胞加速烧伤创面愈合的功效。
Burns Trauma. 2021 Sep 11;9:tkab021. doi: 10.1093/burnst/tkab021. eCollection 2021.
2
In vitro differentiation effect of CCL-induced liver injured mice serum on bone marrow-derived mesenchymal stem cells toward hepatocytes like cells.CCL 诱导肝损伤小鼠血清对骨髓间充质干细胞向肝样细胞分化的体外影响。
Cell Tissue Bank. 2021 Jun;22(2):297-303. doi: 10.1007/s10561-020-09878-5. Epub 2020 Nov 10.
3
Inhibition of the Low Molecular Weight Protein Tyrosine Phosphatase (LMPTP) as a Potential Therapeutic Strategy for Hepatic Progenitor Cells Lipotoxicity-Short Communication.
抑制低分子量蛋白酪氨酸磷酸酶(LMPTP)作为肝前体细胞脂毒性的潜在治疗策略——简短交流。
Int J Mol Sci. 2019 Nov 22;20(23):5873. doi: 10.3390/ijms20235873.
4
Pre-treatments enhance the therapeutic effects of mesenchymal stem cells in liver diseases.预处理可增强间充质干细胞在肝脏疾病中的治疗效果。
J Cell Mol Med. 2020 Jan;24(1):40-49. doi: 10.1111/jcmm.14788. Epub 2019 Nov 6.
5
Mechanisms Underlying Cell Therapy in Liver Fibrosis: An Overview.细胞治疗肝纤维化的作用机制:概述。
Cells. 2019 Oct 29;8(11):1339. doi: 10.3390/cells8111339.
6
Current understanding of adipose-derived mesenchymal stem cell-based therapies in liver diseases.目前对基于脂肪源性间充质干细胞的肝脏疾病治疗方法的认识。
Stem Cell Res Ther. 2019 Jul 8;10(1):199. doi: 10.1186/s13287-019-1310-1.
7
Strategies to improve the efficiency of mesenchymal stem cell transplantation for reversal of liver fibrosis.提高间充质干细胞移植逆转肝纤维化效率的策略。
J Cell Mol Med. 2019 Mar;23(3):1657-1670. doi: 10.1111/jcmm.14115. Epub 2019 Jan 11.